HLA Expression at the Maternal‐Fetal Interface

Pregancy in the human presents an “immunological paradox,” because of the unexpected willingness of mothers to accept genetically disparate tissues. The fact that the fetus can develop unharmed for nine months shows that protective mechanisms must exist to permit its survival. The conditions that pe...

Full description

Saved in:
Bibliographic Details
Published inClinical & developmental immunology Vol. 6; no. 3-4; pp. 197 - 204
Main Authors Hutter, Heinz, Hammer, Astrid, Dohr, Gottfried, Hunt, Joan S.
Format Journal Article
LanguageEnglish
Published England Hindawi Publishing Corporation 1998
Wiley
Subjects
Online AccessGet full text
ISSN2314-8861
1044-6672
1740-2522
2314-7156
1740-2530
DOI10.1155/1998/65065

Cover

More Information
Summary:Pregancy in the human presents an “immunological paradox,” because of the unexpected willingness of mothers to accept genetically disparate tissues. The fact that the fetus can develop unharmed for nine months shows that protective mechanisms must exist to permit its survival. The conditions that permit the genetically dissimilar human fetus to evade rejection by its mother′s immune system have been the subject of intense interest for several decades. As the placental cells, which are in contact with maternal blood or tissue, are devoid of HLA class II antigens, interest has focused on the expression of HLA class molecules. Recent developments in the constitutive, transcriptional, and translational expression of HLA class I molecules on anatomically and morphologically different subpopulations of trophoblast cells will form the basis of this short review.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:2314-8861
1044-6672
1740-2522
2314-7156
1740-2530
DOI:10.1155/1998/65065